Evidence map›Paper›PMID 31068920›Full record

ArticleFrontiers in microbiology2019

Increased

Iliana Claudia Balga Milian, Rafaela José Silva, Camilla Manzan-Martins, Bellisa Freitas Barbosa, Pamela Mendonça Guirelli, Mayara Ribeiro, Angelica de Oliveira Gomes, Francesca Ietta, José Roberto Mineo, Priscila Silva Franco and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2025
    Article
  4. The roles of COX-2 in protozoan infection.Frontiers in immunology · 2023
    Review
  5. Modeling the human placental barrier to understandFrontiers in cellular and infection microbiology · 2023
    Review
  6. Frontiers in immunology · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Biogenic Silver Nanoparticles Can ControlFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Iliana Claudia Balga MilianLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Rafaela José SilvaLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Camilla Manzan-MartinsLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Bellisa Freitas BarbosaLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Pamela Mendonça GuirelliLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Mayara RibeiroLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Angelica de Oliveira GomesDepartment of Morphology, Federal University of the Triângulo Mineiro, Uberaba, Brazil.
Francesca IettaDepartment of Life Sciences, University of Siena, Siena, Italy.
José Roberto MineoLaboratory of Immunoparasitology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, Brazil.
Priscila Silva FrancoLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Eloisa Amália Vieira FerroLaboratory of Immunophysiology of Reproduction, Institute of Biomedical Science, Federal University of Uberlândia, Uberlândia, Brazil.
Universidade Federal de Uberlândia · BRUniversidade Federal do Triângulo Mineiro · BRUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage migration inhibitory factor (MIF) is a potent pro-inflammatory cytokine, which mediates the regulation of diverse cellular functions. It is produced by extravillous trophoblastic cells and has been found to be involved in the pathogenesis of diseases caused by some protozoa, including

Indexed as

CD44COX-2ERK1/2 phosphorylationmacrophage migration inhibitor factor (MIF)Toxoplasma gondii

Identifiers

PMID31068920
PMCPMC6491458
OpenAlexW2939340743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.